Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 5
1967 2
1968 2
1969 4
1970 2
1971 1
1972 1
1973 2
1974 4
1976 10
1977 4
1978 5
1979 5
1980 7
1981 8
1982 6
1983 6
1984 13
1985 7
1986 17
1987 13
1988 25
1989 25
1990 24
1991 35
1992 45
1993 48
1994 64
1995 50
1996 63
1997 86
1998 100
1999 136
2000 193
2001 201
2002 233
2003 299
2004 315
2005 387
2006 428
2007 456
2008 532
2009 634
2010 760
2011 869
2012 955
2013 1088
2014 1064
2015 1125
2016 1169
2017 1212
2018 1222
2019 1258
2020 1375
2021 1473
2022 1322
2023 123
Text availability
Article attribute
Article type
Publication date

Search Results

17,323 results
Results by year
Filters applied: . Clear all
Page 1
Fractional Flow Reserve or Intravascular Ultrasonography to Guide PCI.
Koo BK, Hu X, Kang J, Zhang J, Jiang J, Hahn JY, Nam CW, Doh JH, Lee BK, Kim W, Huang J, Jiang F, Zhou H, Chen P, Tang L, Jiang W, Chen X, He W, Ahn SG, Yoon MH, Kim U, Lee JM, Hwang D, Ki YJ, Shin ES, Kim HS, Tahk SJ, Wang J; FLAVOUR Investigators. Koo BK, et al. Among authors: kim w. N Engl J Med. 2022 Sep 1;387(9):779-789. doi: 10.1056/NEJMoa2201546. N Engl J Med. 2022. PMID: 36053504 Clinical Trial.
METTL16 antagonizes MRE11-mediated DNA end resection and confers synthetic lethality to PARP inhibition in pancreatic ductal adenocarcinoma.
Zeng X, Zhao F, Cui G, Zhang Y, Deshpande RA, Chen Y, Deng M, Kloeber JA, Shi Y, Zhou Q, Zhang C, Hou J, Kim W, Tu X, Yan Y, Xu Z, Chen L, Gao H, Guo G, Liu J, Zhu Q, Cao Y, Huang J, Wu Z, Zhu S, Yin P, Luo K, Mer G, Paull TT, Yuan J, Tao K, Lou Z. Zeng X, et al. Among authors: kim w. Nat Cancer. 2022 Sep;3(9):1088-1104. doi: 10.1038/s43018-022-00429-3. Epub 2022 Sep 22. Nat Cancer. 2022. PMID: 36138131
Routine Functional Testing or Standard Care in High-Risk Patients after PCI.
Park DW, Kang DY, Ahn JM, Yun SC, Yoon YH, Hur SH, Lee CH, Kim WJ, Kang SH, Park CS, Lee BK, Suh JW, Yoon JH, Choi JW, Kim KS, Choi SW, Lee SN, Park SJ; POST-PCI Investigators. Park DW, et al. Among authors: kim wj. N Engl J Med. 2022 Sep 8;387(10):905-915. doi: 10.1056/NEJMoa2208335. Epub 2022 Aug 28. N Engl J Med. 2022. PMID: 36036496 Clinical Trial.
MET-Induced CD73 Restrains STING-Mediated Immunogenicity of EGFR-Mutant Lung Cancer.
Yoshida R, Saigi M, Tani T, Springer BF, Shibata H, Kitajima S, Mahadevan NR, Campisi M, Kim W, Kobayashi Y, Thai TC, Haratani K, Yamamoto Y, Sundararaman SK, Knelson EH, Vajdi A, Canadas I, Uppaluri R, Paweletz CP, Miret JJ, Lizotte PH, Gokhale PC, Jänne PA, Barbie DA. Yoshida R, et al. Among authors: kim w. Cancer Res. 2022 Nov 2;82(21):4079-4092. doi: 10.1158/0008-5472.CAN-22-0770. Cancer Res. 2022. PMID: 36066413 Free PMC article.
Interaction between Sarcopenia and NAFLD.
Joo SK, Kim W. Joo SK, et al. Among authors: kim w. Clin Mol Hepatol. 2022 Dec 5. doi: 10.3350/cmh.2022.0358. Online ahead of print. Clin Mol Hepatol. 2022. PMID: 36472051 Free article. Review.
Ginseng and ginsenosides: Therapeutic potential for sarcopenia.
Zha W, Sun Y, Gong W, Li L, Kim W, Li H. Zha W, et al. Among authors: kim w. Biomed Pharmacother. 2022 Dec;156:113876. doi: 10.1016/j.biopha.2022.113876. Epub 2022 Oct 19. Biomed Pharmacother. 2022. PMID: 36270259 Free article. Review.
The Effect of Ginger and Its Sub-Components on Pain.
Kim S, Cheon C, Kim B, Kim W. Kim S, et al. Among authors: kim w. Plants (Basel). 2022 Sep 2;11(17):2296. doi: 10.3390/plants11172296. Plants (Basel). 2022. PMID: 36079679 Free PMC article. Review.
17,323 results
You have reached the last available page of results. Please see the User Guide for more information.